experiment because of the known retardation of digoxin absorption due to feeding before administration of drug (White et al., 1971) . These results are similar to, and serve as a model for, those found when different oral formulations of digoxin were tested (Doherty, 1968; Lindenbaum et al., 1971; Manninen et al., 1971; Binnion and McDermott, 1972; Hibble et al., 1972) . Our data could be falsely interpreted to indicate differences in bioavailability with respect to both the extent and rate of drug absorption. Such a conclusion is clearly contraindicated by the virtually identical urinary data in both experiments, suggesting identical extent of bioavailability in both settings.
Nonetheless, statements regarding digoxin bioavailability are still being made on the basis of peak serum levels alone (Butler, 1972; Lancet, 1972) . The physician who must interpret data pertaining to the bioavailability of any drug in oral formulation, and of digoxin in particular, should be aware of the potential erroneous conclusions when only a single method of estimating bioavailability is used. The best studies would use at least three methods in the same subject and relate bioavailability to expected pharmacological effect.
Introduction
Sympathomimetics are thought to be more effective than anticholinergics in relieving bronchospasm in most asthmatics, and they are widely used in the treatment of patients with various kinds of obstructive lung diseases. In patients with chronic bronchitis, however, the bronchodilator effect of anticholinergic drugs is comparable to that of sympathomimetics (Altounyan, 1964; Crompton, 1968; Ulmer, 1971) . Poppius et al. (1972) found that inhalation of a new anticholinergic drug, Sch 1000 (Boehringer Ingelheim), was followed by a bronchodilation response which was submaximal in a group of asthma patients but maximal in one of bronchitic patients- (Poppius, 1965) . All patients had an FEV% value below 60%, the mean FEV% being 43%. The mean increase in FEV1 after isoprenaline inhalation was 15% (S.D. 11%).
Because airways resistance depends on the lung volume, the reciprocal of airways resistance divided by the respective volume or the specific airways conductance (SGaw) and the thoracic gas volume at the end-tidal level (Vtg) were determined at a breathing frequency of 30/min with a constant volume body plethysmograph (Siregnost, Siemens) (Woitowitz et al., 1967) . Peak expiratory flow (PEF) during forced expiration, which is widely used to assess the degree of obstruction, was measured with a Wright peak flow meter.
The patients were studied between 9 a.m. and 2 p.m. on three consecutive days. Bronchodilators were omitted for at least seven hours before the tests, and the patients told to avoid coffee, tea, and smoking on the test days. After measurements of SGaw, Vtg, and PEF the patients inhaled either two 20 i'g puffs of Sch 1000, two 100 jig puffs of salbutamol, or two puffs of placebo according to a double-blind cross-over arrangement, the sequence of drugs being randomly varied. After the inhalation of drugs the PEF measurements were repeated after 15 minutes and after one, two, three, and four hours and the SGaw and Vtg measurements after two hours. The body plethysmographic measurements always preceded the PEF measurements. At the end of the experiment-that is, after four hours of follow-up-the patient inhaled two 100 ,ug puffs of isoprenaline. Five minutes later the PEF measurements were repeated. The heart rate was measured before each PEF measurement.
Differences between the treatment groups with regard to the percentage change in PEF and the absolute changes in SGaw and Vtg from the respective pretreatment values were evaluated with the paired t-test. The SGaw data were logarithmically transformed before statistical treatment.
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The intraindividual variation of pretreatment SGaw values in the Sch 1000 and salbutamol experiments was assessed by calculating the standard deviation of the difference between the respective log SGaw values. The antilog of this standard deviation value was 0-738 sec-lcmH2O-1. SGaw increased more after Sch 1000 than after salbutamol (P < 0 05) and more after salbutamol than after the placebo (P < 0 001) ( fig. 2) 
Results
The pretreatment PEF values (mean ± S.E. of mean) were 184 ± 14 1./min with Sch 1000, 182 ± 15 1./min with salbutamol, and 179 ± 14 1./min with placebo. The standard deviation of the intraindividual difference between pretreatment PEF values obtained in the Sch 1000 and the salbutamol experiments was 27 l./min. Both active drugs produced a rise in PEF ( fig. 1) . The difference from the placebo was still Sch 1000 and salbutamol were followed by an equal decrease in Vtg and differed in this respect from placebo (P < 0-01) ( fig. 3) .
A slight and equal drop in heart rate was seen in all three treatment groups. In the subjective evaluation of drugs Sch 1000 was preferred by five patients, salbutamol by four, and placebo by two patients. On specific inquiry, dryness of mouth was reported by two patients in the Sch 1000, two in the salbutamol, and four in the placebo experiments. 
Discussion
The mechanism of bronchoconstriction and the relative effects of sympathomimetics and anticholinergics may depend on the clinical type of disease. Evaluation and comparison of results of trials on bronchodilators may be hampered by the fact that "mixed" groups of patients with airways obstruction are used in the studies. We have therefore tried to select and characterize our material according to stated clinical criteria.
In the present series of bronchitics Sch 1000 produced a larger increase in SGaw measured two hours after the inhalation of the drug than salbutamol. The bronchodilation effect of Sch 1000 also seemed to persist longer, since inhalation of isoprenaline after four hours of follow-up produced a larger increase in PEF in the salbutamol experiment than in the Sch 1000 experiment. Hence with the therapeutically recommended doses used Sch 1000 seems to compare favourably with salbutamol with regard to the bronchodilation effect in patients with chronic bronchitis.
The lack of side effects, such as on heart rate or others, after the anticholinergic drug in this short-term experiment may also be noted. The effect on the mucociliary performance cannot be assessed from this experiment, but dryness of mouth was reported only on specific inquiry and occurred twice after both salbutamol and Sch 1000, and in four cases after placebo. al., 1972; Lawson and Mitchell, 1972; Patel et al., 1972; Smith, 1972) . During 1970 at the Regional Poisoning Treatment Centre, Royal Infirmary, Edinburgh, an increase in the number of patients taking drugs "for kicks"-that is, for their pleasurable effect in order to become intoxicated-was noted. Little information has been published about this aspect of selfpoisoning; hence in 1971 a prospective study was started to ascertain the incidence of admissions to this centre resulting from the taking of drugs for kicks, the type of drugs involved, and the characteristics of these patients. This paper reviews the 252 admissions resulting from this type of drug taking during 1971 and 1972. Patients and Methods The Regional Poisoning Treatment Centre serves a population of about half a million in Edinburgh and the surrounding district, and most poisoned patients presenting at other hospitals are referred here. All poisoned patients from 12 years of age are admitted, regardless of the severity of the poisoning, and this admission policy has not changed for many years (Matthew and Lawson, 1970) . In 1962 (Kessel et al., 1964 ) and 1967 (Matthew et al., 1969) 90 and 95% respectively of all poisoned adults admitted to hospital from the catchment area passed through this unit.
All patients were examined on admission by a resident medical officer and certain facts recorded. As soon as practicable after regaining consciousness all patients were examined by both a physician and a psychiatrist and only if both were in agreement that from the history, clinical examination, or circumstantial evidence or a combination of these factors that the admission was the direct result of having taken drugs for kicks was the patient included in the study.
This study does not include 56 patients admitted because of
